Regen BioPharma Inc 10-K Cybersecurity GRC - 2025-05-13

Page last updated on May 26, 2025

Regen BioPharma Inc reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-05-13 16:30:37 EDT.

Filings

10-K filed on 2025-05-13

Regen BioPharma Inc filed a 10-K at 2025-05-13 16:30:37 EDT
Accession Number: 0001641172-25-009968

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C. CYBERSECURITY Cybersecurity Risk Management and Strategy The Company’s Chief Executive Officer assesses risks from cybersecurity threats on an ongoing basis. As the Company grows it plans to develop a more robust and detailed strategy for cybersecurity. The Company has not encountered cybersecurity challenges that have materially impaired operations or financial condition. The Company does not believe that there are currently any known risks from cybersecurity threats that are reasonably likely to materially affect us or our business strategy, results of operations or financial condition. Governance; Board Oversight The Company’s sole director and officer provides direct oversight over cybersecurity risk.

Company Information